Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Daixi Ren(Central South University), Wei Xiong(Hainan Medical University), Yunhua Chen(Key Laboratory of Guangdong Province), Yujuan Zhou(Hunan Cancer Hospital), Xiaoxu Wei(Central South University), Qianjin Liao(Hunan Normal University), Bo Xiang(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Zhaoyang Zeng(Shenzhen Academy of Robotics), Ming Zhou(Zhejiang Chinese Medical University), Yongzhen Mo(Central South University), Guiyuan Li(Xuzhou Medical College), Xin Ye(Beihua University), Yong Li(Baylor College of Medicine), Xiaoling Li(Southwest University), Jie Wang(Fujian Medical University), Hui Wang(Peking University), Chun‐Wei Li(Central South University), Yuze Hua(Chinese Academy of Medical Sciences & Peking Union Medical College), Boyao Yu(Central South University), Ziheng He(Central South University)
Cited by 10
Related Papers
The cancer metabolic reprogramming and immune response
|Molecular Cancer|2021|1.3k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662